Literature DB >> 18854207

Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.

J Spampanato1, X Gu, X W Yang, I Mody.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by a polyglutamine repeat expansion in huntingtin. A newly developed bacterial artificial chromosome transgenic mouse model (BACHD) reproduces phenotypic features of HD including predominantly neuropil-associated protein aggregation and progressive motor dysfunction with selective neurodegenerative pathology. Motor dysfunction has been shown to precede neuropathology in BACHD mice. We therefore investigated the progression of synaptic pathology in pyramidal cells and interneurons of the superficial motor cortex of BACHD mice. Whole-cell patch clamp recordings were performed on layer 2/3 primary motor cortical pyramidal cells and parvalbumin interneurons from BACHD mice at 3 months, when the mice begin to demonstrate mild motor dysfunction, and at 6 months, when the motor dysfunction is more severe. Changes in synaptic variances were detectable at 3 months, and at 6 months BACHD mice display progressive synaptic pathology in the form of reduced cortical excitation and loss of inhibition onto pyramidal cells. These results suggest that progressive alterations of the superficial cortical circuitry may contribute to the decline of motor function in BACHD mice. The synaptic pathology occurs prior to neuronal degeneration and may therefore prove useful as a target for future therapeutic design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854207      PMCID: PMC2802129          DOI: 10.1016/j.neuroscience.2008.09.020

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  66 in total

1.  Modulation of network behaviour by changes in variance in interneuronal properties.

Authors:  I Aradi; I Soltesz
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

Review 2.  The thalamic matrix and thalamocortical synchrony.

Authors:  E G Jones
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

Review 3.  Interlaminar connections in the neocortex.

Authors:  Alex M Thomson; A Peter Bannister
Journal:  Cereb Cortex       Date:  2003-01       Impact factor: 5.357

4.  Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.

Authors:  G A Laforet; E Sapp; K Chase; C McIntyre; F M Boyce; M Campbell; B A Cadigan; L Warzecki; D A Tagle; P H Reddy; C Cepeda; C R Calvert; E S Jokel; G J Klapstein; M A Ariano; M S Levine; M DiFiglia; N Aronin
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression.

Authors:  A W Deckel; A Gordinier; D Nuttal; V Tang; C Kuwada; R Freitas; K A Gary
Journal:  Brain Res       Date:  2001-11-16       Impact factor: 3.252

6.  Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation.

Authors:  K P Murphy; R J Carter; L A Lione; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

7.  Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo.

Authors:  Thomas Klausberger; Peter J Magill; László F Márton; J David B Roberts; Philip M Cobden; György Buzsáki; Peter Somogyi
Journal:  Nature       Date:  2003-02-20       Impact factor: 49.962

8.  Biphasic developmental changes in Ca2+/calmodulin-dependent proteins in R6/2 Huntington's disease mice.

Authors:  A Wallace Deckel; Robert Elder; Greg Fuhrer
Journal:  Neuroreport       Date:  2002-04-16       Impact factor: 1.837

9.  Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.

Authors:  Carlos Cepeda; Raymond S Hurst; Christopher R Calvert; Elizabeth Hernández-Echeagaray; Oanh K Nguyen; Emily Jocoy; Lindsey J Christian; Marjorie A Ariano; Michael S Levine
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites.

Authors:  Jessica A Gorski; Steven R Zeiler; Susan Tamowski; Kevin R Jones
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

View more
  40 in total

1.  Disrupted GABAAR trafficking and synaptic inhibition in a mouse model of Huntington's disease.

Authors:  Eunice Y Yuen; Jing Wei; Ping Zhong; Zhen Yan
Journal:  Neurobiol Dis       Date:  2012-02-28       Impact factor: 5.996

2.  Parvalbumin deficiency and GABAergic dysfunction in mice lacking PGC-1alpha.

Authors:  Elizabeth K Lucas; Sean J Markwardt; Swati Gupta; James H Meador-Woodruff; Jiandie D Lin; Linda Overstreet-Wadiche; Rita M Cowell
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Hyperactivity and cortical disinhibition in mice with restricted expression of mutant huntingtin to parvalbumin-positive cells.

Authors:  S E Dougherty; J J Hollimon; L J McMeekin; A S Bohannon; A B West; M Lesort; J J Hablitz; R M Cowell
Journal:  Neurobiol Dis       Date:  2013-10-11       Impact factor: 5.996

Review 4.  Huntington's disease: can mice lead the way to treatment?

Authors:  Zachary R Crook; David Housman
Journal:  Neuron       Date:  2011-02-10       Impact factor: 17.173

Review 5.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

6.  Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.

Authors:  Ana María Estrada-Sánchez; George V Rebec
Journal:  Basal Ganglia       Date:  2012-07-01

7.  A small molecule TrkB ligand reduces motor impairment and neuropathology in R6/2 and BACHD mouse models of Huntington's disease.

Authors:  Danielle A Simmons; Nadia P Belichenko; Tao Yang; Christina Condon; Marie Monbureau; Mehrdad Shamloo; Deqiang Jing; Stephen M Massa; Frank M Longo
Journal:  J Neurosci       Date:  2013-11-27       Impact factor: 6.167

8.  Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.

Authors:  Ana María Estrada-Sánchez; Courtney L Burroughs; Stephen Cavaliere; Scott J Barton; Shirley Chen; X William Yang; George V Rebec
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

Review 9.  Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.

Authors:  Carlos Cepeda; Damian M Cummings; Véronique M André; Sandra M Holley; Michael S Levine
Journal:  ASN Neuro       Date:  2010-04-07       Impact factor: 4.146

Review 10.  Establishing a physiological environment for visualized in vitro brain slice recordings by increasing oxygen supply and modifying aCSF content.

Authors:  Norbert Hájos; Istvan Mody
Journal:  J Neurosci Methods       Date:  2009-06-12       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.